CJC-1295 + Ipamorelin pairs two different endocrine-signalling references in one blend. CJC-1295 no-DAC belongs to GHRH receptor literature, while Ipamorelin belongs to ghrelin receptor and growth hormone secretagogue receptor literature.
That pairing is useful because the two components are not doing the same thing. One side represents GHRH-pathway signalling, and the other represents GHSR-pathway signalling, giving customers a practical blend for comparing upstream endocrine pathway activity.
The product reads as a component-based blend, not as a single new molecule. The description explains the logic of the pairing, while the specification table gives the component identities, amounts, and analytical details.
The references below are starting points for the mechanisms discussed here. The specification table on this page covers identity, formula, molecular mass, physical form, solubility, storage, and lot-level analytical information.
References
- PubMed: modified GRF(1-29)
- PubMed: Ipamorelin ghrelin receptor
- PubMed: growth hormone secretagogue receptor peptides
- PubChem search: Ipamorelin CJC-1295
Research-use notice: Supplied strictly for lawful research, laboratory, analytical, educational, or R&D purposes where permitted by applicable law. Not for human or animal use, consumption, diagnosis, treatment, food, supplement, cosmetic, veterinary, or similar end use.




